AbbVie to buy Botox-maker Allergan in $63 billion deal



AbbVie Inc said on Tuesday it would buy Botox-maker Allergan Plc in a cash-and-stock deal for about $63 billion to add fast-growing therapeutic businesses such as medical aesthetics and eye care.

Read on Reuters